| Wednesday, February 27, 2019 Here's What's Happening with Cannabis Legalization in New York and New Jersey By Greg Miller
Cannabis legalization was a key issue for voters in the 2018 U.S. elections: Michigan legalized recreational use and Utah and Missouri legalized medical cannabis. That's a good start, but the news gets even better - and bigger - in 2019.
New York and New Jersey, two of the most populous U.S. states, could be the next to legalize recreational cannabis.
Governor Andrew Cuomo (NY-D) expects his state could raise about $300 million in annual revenue from legalization. Governor Phil Murphy (NJ-D) also believes New Jersey could generate a similar amount of revenue, according to Bloomberg.
And it's clear that residents of each state want legalization.
According to a 2018 Quinnipiac University poll, 63% of New York voters favor legalizing cannabis. For New Jersey, a 2018 poll by Rutgers University's Eagleton Center for Public Interest Polling found that 60% of New Jersey adults wanted legalization.
But if the majority of folks want this to happen, what's the hold up?
Today, I wanted to give you an update on the legalization efforts in these two states.
The Big Apple and the Garden State could be huge cannabis markets, and companies expanding into New York and New Jersey could rake in massive profits...
How to Become an Angel Investor in Tomorrow's Biggest Cannabis Company
For years, Angel Investing was reserved for America's most elite investors - only the wealthiest 2% could secure a deal. But not anymore. Thanks to a recent federal law change, you don't have to be a multi-millionaire to break into the startup market. In fact, average investors now have the chance to make a run at these opportunities before the bigger players move in. And let me tell you, the profit potential at stake is too good to ignore. Better yet, the next company to deliver a potential windfall... we believe it'll be a cannabis company. In fact, our analysts believe it'll be the cannabis company we recently shared with our readers. And if you click here now, we'll show you how you can become an angel investor in America's next great industry.
When was the last time you made $116,800 in 9 months with zero work? That's exactly what happened to folks who got into Auxly Group on IPO day. All they had to do was put in $2,000 on IPO day and 9 months later they'd be sitting on $109,600 in pure profits. And that's just the tip of the iceberg. The simple fact is, nothing is more profitable than a successful IPO. But not every IPO is going to turn you into a millionaire. That's why I sat down with the world's #1 authority on IPOs. He's a Wall Street refugee who quit his job at one of the world's largest investment banks a few years ago to start his own venture capital fund. And in the last 18 months, the IPOs he's run have made BILLIONS for investors. And all you have to do is click here to listen to what he has to say for yourself.
|
You are receiving this e-mail at its028@gmail.com, as a part of your subscription.
Remove your email from this list: Unsubscribe
© 2019 The National Institute for Cannabis Investors All Rights Reserved The National Institute for Cannabis Investors | 1125 N Charles Street | Baltimore, MD 21201 Toll Free: 866.260.0361; International: 410.777.8270 Contact Customer Service Website: https://nicinvestors.com
Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice.
We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your financial adviser and only after reviewing the prospectus or financial statements of the company.
Protected by copyright laws of the United States and international treaties. This information may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The National Institute for Cannabis Investors, 1125 N Charles Street, Baltimore, MD 21201.
Privacy Policy | Terms & Conditions
| |
没有评论:
发表评论